Cellosaurus MT1 (CVCL_E8BN)
Cell line name | MT1 |
---|---|
Accession | CVCL_E8BN |
Resource Identification Initiative | To cite this cell line use: MT1 (RRID:CVCL_E8BN) |
Comments | Population: Caucasian. Characteristics: Able to survive the cytotoxic effects of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Sensitive to mutagenesis by MNNG and display a mutator phenotype (PubMed=3745200). Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191). Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Omics: Transcriptomics; Microarray. Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Cell type: B-cell; CL=CL_0000236. |
Sequence variations |
|
Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0561 (TK6) |
Sex of cell | Male |
Age at sampling | 5Y |
Category | Transformed cell line |
Publications | PubMed=3745200; DOI=10.1016/S0021-9258(18)67110-8 PubMed=8341649; DOI=10.1073/pnas.90.14.6424; PMCID=PMC46944 PubMed=18805990; DOI=10.1101/gad.1688508; PMCID=PMC2559901 |
Cross-references | |
Gene expression databases | GEO; GSM260649
GEO; GSM260650 GEO; GSM260651 GEO; GSM260652 |
Entry history | |
Entry creation | 10-Apr-2025 |
Last entry update | 10-Apr-2025 |
Version number | 1 |